HealthQuill Pharma
Johnson & Johnson plans to acquire Israel’s privately-held V-Wave Ltd., for an upfront payment of $600 million, according to a statement from the US-based company.
Drugs Health Pharma

J&J plans to acquire Israel’s V-Wave by paying $600 million upfront

Johnson & Johnson plans to acquire Israel’s privately-held V-Wave Ltd., for an upfront payment of $600 million, according to a statement from the.

Read More
Walgreens Boots Alliance Inc., the second-largest pharmacy store chain in the US has bagged a $100 million gov­ern­ment fund­ing to ex­pand its clin­i­cal tri­al ca­pa­bil­i­ties, according to the company.
Drugs Health Pharma

Walgreens grabs $100 million from US government for decentralized trials

Walgreens Boots Alliance Inc., the second-largest pharmacy store chain in the US has bagged a $100 million gov­ern­ment fund­ing to ex­pand its clin­i­cal.

Read More
China’s drug regulator, the National Medical Products Association, has approved AstraZeneca Plc’s asthma drug.
Drugs Health Pharma

AstraZeneca’s asthma drug gets regulator’s approval in China

China’s drug regulator, the National Medical Products Association, has approved  AstraZeneca Plc’s asthma drug.

Read More
A new strain of monkeypox virus named as MPXV clade Ib, which originated in the Democratic Republic of the Congo recently, is behind the surge of cases reported and transmitted through sexual contact.
Drugs Health Pharma

New mpox virus strain, sexual contact, behind a surge in cases: WHO 

A new strain of monkeypox virus named as MPXV clade Ib, which originated in the Democratic Republic of the Congo recently, is behind.

Read More
Arbutus Biopharma Corporation and Genevant Sciences filed a lawsuit in a US court seeking compensation for Pfizer and BioNTech’s unlicensed use of its patents in making COVID-19 vaccines.
Health Medical Pharma

J&J’s $6.5B settlement plan amid ongoing talc lawsuits finds favour

HQ Team August 14, 2024: Johnson & Johnson (J&J) is nearing settlement of lawsuits alleging that its talc-based baby powder caused cancer. Over.

Read More
Pfizer Inc.’s vaccine trials on patients aged 18 and older with chronic respiratory diseases show a consistent safety profile and “strong neutralizing responses,” after a single jab, according to a company statement. 
Drugs Health Pharma

‘Strong neutralizing responses’ shown in RSV vaccine trials: Pfizer says

Pfizer Inc.’s vaccine trials on patients aged 18 and older with chronic respiratory diseases show a consistent safety profile and “strong neutralizing responses,”.

Read More
ARS Pharmaceuticals, a US-based biopharmaceutical company, got the nation’s drug regulator’s approval for a nasal spray to treat allergic reactions in adult and paediatric patients.
Drugs Health Pharma

US-based ARS’s nasal spray to treat allergic reactions gets FDA nod

ARS Pharmaceuticals, a US-based biopharmaceutical company, got the nation’s drug regulator’s approval for a nasal spray to treat allergic reactions in adult and.

Read More
Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory body, according to the company.
Drugs Health Pharma

US regulator rejects Lykos’s MDMA therapy, wants more data 

Lykos Therapeutics’s ecstasy drug or midomafetamine capsules for the treatment of post-traumatic stress disorder in adults was rejected by the US drug regulatory.

Read More
When parents share unflattering or embarrassing images, it can lead to feelings of humiliation and a distorted self-image. Children may struggle with their identity when they grow older, especially if their online presence has been shaped without their consent.
Drugs Health Pharma

‘Sharenting’: The risks of oversharing your children’s life online

When parents share unflattering or embarrassing images, it can lead to feelings of humiliation and a distorted self-image. Children may struggle with their.

Read More
Citius Pharmaceuticals, Inc., a US-based biotechnology company, got a green light from the country’s drug regulator for its immunotherapy treatment for a rare form of blood cancer that affects the skin.
Drugs Health Pharma

Citius’s blood cancer drug gets US regulatory body’s clearance 

Citius Pharmaceuticals, Inc., a US-based biotechnology company, got a green light from the country’s drug regulator for its immunotherapy treatment for a rare.

Read More